Related blood pressure drugs linked to differing dementia risks
Compared with lisinopril, the drugs collectively had a dementia hazard ratio of 0.86, indicating a lower rate of new diagnoses over follow-up.
The retrospective cohort study examined adults aged 55 to 80 starting an angiotensin receptor blocker or lisinopril, two types of blood pressure medicine. Participants had not previously used either drug class. Researchers identified 2,051,275 eligible people using health records and insurance claims from 44 US healthcare organisations. They matched comparison groups on measured characteristics. Median follow-up ranged from 4.7 to 7.2 years.
Angiotensin receptor blockers collectively were associated with lower dementia risk than lisinopril, but associations varied between individual drugs. Their hazard ratios ranged from 0.66 to 0.93 compared with lisinopril. Comparisons between individual blockers also showed differing associations. Losartan, the most commonly prescribed blocker, had the least favourable dementia associations.
Why it matters
Dementia is an age-related disease. The findings raise a question for randomised trials about whether individual blood pressure medicines differ in their effects on dementia risk.
Caveats
This observational study cannot establish causation or rule out unmeasured differences between groups, and the preprint has not been peer-reviewed. The findings concern adults aged 55 to 80 starting these medicines, not established users or people outside that age range.
The paper
Individual Angiotensin Receptor Blockers and Risk of Dementia: A Target Trial Emulation Study
Weill Cornell Medicine
medRxiv, 14 Oct 2026, Open access, Preprint, not peer-reviewed
